New Review on Pharmacological Therapies

A new review titled “Pharmacological Therapies for Connective Tissue Fibrosis in Orthopaedics” by N. Disser has been published in The American Journal of Sports Medicine DOI: 10.1177/03635465221116358

They summarise by stating “Based on our review, it would appear that over-the counter food supplements and ‘‘nutraceuticals’’ hold promise as agents to prevent connective tissue fibrosis with a good safety profile. In particular, EGCG and quercetin appear to be safe and reasonable candidates for further study. FDA-approved medications that may be considered for off-label use for prevention of connective tissue fibrosis include losartan, anakinra, and sotatercept.”